News Releases

March, 2020

March 16, 2020 2020-03-16 COVID19 HCP Letter

February, 2020

February 4, 2020 2020-02-04 Princess Margaret Research Announcement

January, 2020

January 24, 2020 2020-01-24 ON Patients Gain Better Access to INTUNIV XR

November, 2019

November 22, 2019 2019-11-22 TAKHZYRO receives positive CADTH recommendation

July, 2019

July 10, 2019 2019-07-10 Health Canada has authorized VYVANSE® (lisdexamfetamine dimesylate), the first and only, chewable tablet for the treatment of attention deficit/hyperactivity disorder (ADHD)

June, 2019

June 13, 2019 2019-06-13 Pedalling in support of rare disease research

March, 2019

March 11, 2019 2019-03-11 Takeda Canada announces positive results for ENTYVIO®(2)

March 1, 2019 2019-03-01 Takeda Canada commemorates Rare Disease Day with the launch of video patient stories